Industry warily eyes new Medicare drug plan.
Vastag
Brian
B
D001709:Biotechnology / Q000191:economics*; D004345:Drug Industry / Q000191:economics*; D011307:Drug Prescriptions / Q000191:economics*; D006078:Government Programs / Q000191:economics; D007349:Insurance, Health, Reimbursement / Q000191:economics*; D007356:Insurance, Pharmaceutical Services / Q000191:economics*; D006278:Medicare / Q000458:organization & administration*; D014481:United States